Publication rate in preclinical research: a plea for preregistration.

Q1 Medicine
BMJ Open Science Pub Date : 2020-08-27 eCollection Date: 2020-01-01 DOI:10.1136/bmjos-2019-100051
Mira van der Naald, Steven Wenker, Pieter A Doevendans, Kimberley E Wever, Steven A J Chamuleau
{"title":"Publication rate in preclinical research: a plea for preregistration.","authors":"Mira van der Naald, Steven Wenker, Pieter A Doevendans, Kimberley E Wever, Steven A J Chamuleau","doi":"10.1136/bmjos-2019-100051","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>The ultimate goal of biomedical research is the development of new treatment options for patients. Animal models are used if questions cannot be addressed otherwise. Currently, it is widely believed that a large fraction of performed studies are never published, but there are no data that directly address this question.</p><p><strong>Methods: </strong>We have tracked a selection of animal study protocols approved in the University Medical Center Utrecht in the Netherlands, to assess whether these have led to a publication with a follow-up period of 7 years.</p><p><strong>Results: </strong>We found that 60% of all animal study protocols led to at least one publication (full text or abstract). A total of 5590 animals were used in these studies, of which 26% was reported in the resulting publications.</p><p><strong>Conclusions: </strong>The data presented here underline the need for preclinical preregistration, in view of the risk of reporting and publication bias in preclinical research. We plea that all animal study protocols should be prospectively registered on an online, accessible platform to increase transparency and data sharing. To facilitate this, we have developed a platform dedicated to animal study protocol registration: www.preclinicaltrials.eu.</p>","PeriodicalId":9212,"journal":{"name":"BMJ Open Science","volume":" ","pages":"e100051"},"PeriodicalIF":0.0000,"publicationDate":"2020-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647586/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMJ Open Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/bmjos-2019-100051","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: The ultimate goal of biomedical research is the development of new treatment options for patients. Animal models are used if questions cannot be addressed otherwise. Currently, it is widely believed that a large fraction of performed studies are never published, but there are no data that directly address this question.

Methods: We have tracked a selection of animal study protocols approved in the University Medical Center Utrecht in the Netherlands, to assess whether these have led to a publication with a follow-up period of 7 years.

Results: We found that 60% of all animal study protocols led to at least one publication (full text or abstract). A total of 5590 animals were used in these studies, of which 26% was reported in the resulting publications.

Conclusions: The data presented here underline the need for preclinical preregistration, in view of the risk of reporting and publication bias in preclinical research. We plea that all animal study protocols should be prospectively registered on an online, accessible platform to increase transparency and data sharing. To facilitate this, we have developed a platform dedicated to animal study protocol registration: www.preclinicaltrials.eu.

Abstract Image

Abstract Image

临床前研究的发表率:对预注册的呼吁。
目标:生物医学研究的最终目标是为病人开发新的治疗方案。如果无法以其他方式解决问题,就会使用动物模型。目前,人们普遍认为大部分已完成的研究从未发表,但没有数据能直接解决这一问题:方法:我们对荷兰乌得勒支大学医学中心批准的部分动物研究方案进行了跟踪,以评估这些方案是否在 7 年的跟踪期内发表过论文:结果:我们发现,60%的动物研究方案至少发表过一篇论文(全文或摘要)。这些研究共使用了 5590 只动物,其中 26% 的动物在研究后发表了论文:本文提供的数据强调了临床前注册的必要性,因为临床前研究中存在报告和发表偏差的风险。我们认为,所有动物研究方案都应在一个可访问的在线平台上进行前瞻性登记,以提高透明度和数据共享。为此,我们开发了一个专门用于动物研究方案注册的平台:www.preclinicaltrials.eu。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
BMJ Open Science
BMJ Open Science Medicine-General Medicine
CiteScore
10.00
自引率
0.00%
发文量
9
审稿时长
31 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信